First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma
Main Authors: | Nelson Leung, Jennifer A Chapman, Sumeet Bhatia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-11-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.772 |
Similar Items
-
Teclistamab for Multiple Myeloma: Clinical Insights and Practical Considerations for a First-in-Class Bispecific Antibody
by: Pan D, et al.
Published: (2023-07-01) -
Injection site reaction to teclistamab in a patient with multiple myeloma
by: Isabel C. Yoon, BS, et al.
Published: (2025-02-01) -
Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient
by: Panos Arvanitis, et al.
Published: (2024-05-01) -
Teclistamab as an Effective Treatment for Pericardial Effusion in Relapsed Multiple Myeloma: Case Report and a Brief Literature Review
by: Sai Samyuktha Bandaru, et al.
Published: (2024-09-01) -
The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review
by: Razwana Khanam, et al.
Published: (2023-05-01)